doctor-group

Gout Care By Smith & Smith
   



Order 24 hours a day 7 days a week online or by phone!
Call 1-877-633-4688

Search site for information & products:

cart





Customer ReviewsWHAT IS GOUT Video of Uric Acid / Tophi Deposits caused by Gout Attacks in Dissected Big Toe. Pictures of Gout & Tophi
No Risk 100% Money Back Guarantee - GC® GoutCure.com's 100% All Natural Herbal Blend!





Key Points About
Colchicine (Colcrys):


  • Colchicine is prescribed to
    treat or prevent Gout flares

  • Colchicine is not a pain
    medication and should not be
    used as such

  • Colchicine may reduce your
    body's ability to fight infection

  • Patients with liver or kidney
    disease, diabetes, HBP, or
    other serious health conditions
    should consider other
    Gout treatment options

  • Colchicine can cause serious
    side effects that should be
    discussed with your doctor




  • Is Colchicine (Colcrys) a Safe and Effective Gout Treatment?




    colchicine for gout





    COLCHICINE (Colcrys) is used to alleviate attacks. This drug can cause serious side effects and toxicity and even death in high doses.

    Side Effects: 80% of people who take colchicine in doses that are high enough to be effective develop stomach problems, such as cramping, nausea, diarrhea, or vomiting. Serious side effects of colchicine include bone marrow problems, muscle inflammation, severe anemia, and extremely low white blood counts that can increase the risk of infection developing. Colchicine is usually avoided or the dose adjusted in people who have reduced kidney function.



    NCBI- US National Library of Medicine Study: Colchicine poisoning- the dark side of an ancient drug.



    Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348.




    (Finkelstein Y1, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y.)
    Author information
    Abstract


    INTRODUCTION:


    Colchicine is used mainly for the treatment and prevention of gout and for familial Mediterranean fever (FMF). It has a narrow therapeutic index, with no clear-cut distinction between nontoxic, toxic, and lethal doses, causing substantial confusion among clinicians. Although colchicine poisoning is sometimes intentional, unintentional toxicity is common and often associated with a poor outcome.


    METHODS:


    We performed a systematic review by searching OVID MEDLINE between 1966 and January 2010. The search strategy included "colchicine" and "poisoning" or "overdose" or "toxicity" or "intoxication."


    TOXICOKINETICS:


    Colchicine is readily absorbed after oral administration, but undergoes extensive first-pass metabolism. It is widely distributed and binds to intracellular elements. Colchicine is primarily metabolized by the liver, undergoes significant enterohepatic re-circulation, and is also excreted by the kidneys. THERAPEUTIC AND TOXIC DOSES: The usual adult oral doses for FMF is 1.2-2.4 mg/day; in acute gout 1.2 mg/day and for gout prophylaxis 0.5-0.6 mg/day three to four times a week. High fatality rate was reported after acute ingestions exceeding 0.5 mg/kg. The lowest reported lethal doses of oral colchicine are 7-26 mg.


    DRUG INTERACTIONS:


    CYP 3A4 and P-glycoprotein inhibitors, such as clarithromycin, erythromycin, ketoconazole, ciclosporin, and natural grapefruit juice can increase colchicine concentrations. Co-administration with statins may increase the risk of myopathy.


    MECHANISMS OF TOXICITY:


    Colchicine's toxicity is an extension of its mechanism of action - binding to tubulin and disrupting the microtubular network. As a result, affected cells experience impaired protein assembly, decreased endocytosis and exocytosis, altered cell morphology, decreased cellular motility, arrest of mitosis, and interrupted cardiac myocyte conduction and contractility. The culmination of these mechanisms leads to multi-organ dysfunction and failure. REPRODUCTIVE TOXICOLOGY AND LACTATION: Colchicine was not shown to adversely affect reproductive potential in males or females. It crosses the placenta but there is no evidence of fetal toxicity. Colchicine is excreted into breast milk and considered compatible with lactation.


    CLINICAL FEATURES:


    Colchicine poisoning presents in three sequential and usually overlapping phases: 1) 10-24 h after ingestion - gastrointestinal phase mimicking gastroenteritis may be absent after intravenous administration; 2) 24 h to 7 days after ingestion - multi-organ dysfunction. Death results from rapidly progressive multi-organ failure and sepsis. Delayed presentation, pre-existing renal or liver impairment are associated with poor prognosis. 3) Recovery typically occurs within a few weeks of ingestion, and is generally a complete recovery barring complications of the acute illness.


    DIAGNOSIS:


    History of ingestion of tablets, parenteral administration, or consumption of colchicine-containing plants suggest the diagnosis. Colchicine poisoning should be suspected in patients with access to the drug and the typical toxidrome (gastroenteritis, hypotension, lactic acidosis, and prerenal azotemia).


    MANAGEMENT:


    Timely gastrointestinal decontamination should be considered with activated charcoal, and very large, recent (<60 min) ingestions may warrant gastric lavage. Supportive treatments including administration of granulocyte colony-stimulating factor are the mainstay of treatment. Although a specific experimental treatment (Fab fragment antibodies) for colchicine poisoning has been used, it is not commercially available.


    CONCLUSION:


    Although colchicine poisoning is relatively uncommon, it is imperative to recognize its features as it is associated with a high mortality rate when missed. PMID: 20586571 DOI: 10.3109/15563650.2010.495348 [Indexed for MEDLINE]



    See our Gout Treatment Page



    Gout Health & Diet Evaluation


    Gout Stage Assessment











    Credit cards


    Order online 100% securely ~ All your information will be encrypted with 128 bit encryption (high) RSA with 1024 bit exchange.


    We accept Mastercard, Visa, PayPal, and American Express. Copyright 1998-2017 Goutcure.com / Goutcare.com / OrderGC.com / Stopgout.com / Gout-Care.com / AHR4Health.com.
    Alternative Health Research LLC T/A Smith and Smith Enterprises 168 W Main Street Unit 370 New Market, Maryland 21774-0370. All Rights Reserved.

    Privacy Policy



    All Products Page
    Yahoo and Shopper Approved Testimonials
    Privacy Policy
    Question and Answers About Gout Care
    Order Forms
    24 Hour Order Desk
    World Wide Distributors
    Join Our NewsLetter
    Company and Shipping Information







    *These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.